MOH — authorised 26 November 2018
- Marketing authorisation holder: LOXO ONCOLOGY INC
- Status: likely_approved
🇮🇱 Vitrakvi in Israel
MOH authorised Vitrakvi on 26 November 2018
Marketing authorisation
Vitrakvi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Vitrakvi approved in Israel?
Yes. MOH authorised it on 26 November 2018.
Who is the marketing authorisation holder for Vitrakvi in Israel?
LOXO ONCOLOGY INC holds the Israeli marketing authorisation.